Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1343383 | 0.94 | KMT2A (0.61) | KMT2APOLBALDH1A1MEN1RAB9A | |
| SCHEMBL27332955 | 0.83 | L3MBTL1 (0.61) | KMT2AHTTL3MBTL1LMNA | |
| SCHEMBL4344258 | 0.80 | TSHR (0.57) | KMT2APOLBALDH1A1L3MBTL1LMNA | |
| SCHEMBL1343753 | 0.80 | L3MBTL1 (0.44) | KMT2APOLBALDH1A1MAPTL3MBTL1 | |
| SCHEMBL9003054 | 0.79 | KMT2A (0.68) | KMT2APOLBALDH1A1MEN1RAB9A | |
| SCHEMBL9003051 | 0.79 | KMT2A (0.68) | KMT2APOLBALDH1A1MEN1RAB9A | |
| SCHEMBL14518854 | 0.78 | L3MBTL1 (0.43) | KMT2APOLBALDH1A1ATMMAPT | |
| SCHEMBL7384303 | 0.77 | POLB (0.56) | KMT2APOLBALDH1A1MEN1RAB9A | |
| SCHEMBL9029302 | 0.76 | L3MBTL1 (0.41) | KMT2APOLBALDH1A1MEN1ATM | |
| SCHEMBL9029295 | 0.76 | L3MBTL1 (0.41) | KMT2APOLBALDH1A1MEN1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1716152-A2 | FUSED HETROCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | AstraZeneca AB (SE) | 2006-11-02 | — | — | EP | disclosed |
| WO-2005080397-A2 | FUSED HETROCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | ASTRAZENECA AB (SE) | 2005-09-01 | — | — | WO | disclosed |